Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick A Thompson

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Cancer Chemotherapy and Pharmacology|November 30, 2018
A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicitiesJennifer H Foster, Patrick A Thompson, M Brooke Bernhardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112)Patrick A Thompson, Rachid Drissi, Jodi A Muscal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group studyTerzah M Horton, Debananda Pati, Sharon E Plon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 9, 2015
Identifying gene disruptions in novel balanced de novo constitutional translocations in childhood cancer patients by whole-genome sequencingDeborah I Ritter, Katherine Haines, Hannah Cheung, et al.
Journal of Pediatric Surgery|November 27, 2015
Relapsed hepatoblastoma confined to the lung is effectively treated with pulmonary metastasectomyYan Shi, James I Geller, Irene T Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group StudyTerzah M Horton, Patrick A Thompson, Stacey L Berg, et al.
Journal of Pediatric Surgery|March 10, 2015
Focal nodular hyperplasia in children: an institutional experience with review of the literatureIrene T Ma, Yesenia Rojas, Prakash M Masand, et al.
Cancer Chemotherapy and Pharmacology|June 16, 2009
Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primatesJodi A Muscal, Patrick A Thompson, Vincent L Giranda, et al.
Pediatric Blood & Cancer|August 14, 2012
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916)Jodi A Muscal, Patrick A Thompson, Terzah M Horton, et al.
Neuro-Oncology|April 18, 2013
Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomasLindsay B Kilburn, Mehmet Kocak, Franziska Schaedeli Stark, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|November 30, 2018
A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicitiesJennifer H Foster, Patrick A Thompson, M Brooke Bernhardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112)Patrick A Thompson, Rachid Drissi, Jodi A Muscal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group studyTerzah M Horton, Debananda Pati, Sharon E Plon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 9, 2015
Identifying gene disruptions in novel balanced de novo constitutional translocations in childhood cancer patients by whole-genome sequencingDeborah I Ritter, Katherine Haines, Hannah Cheung, et al.
Journal of Pediatric Surgery|November 27, 2015
Relapsed hepatoblastoma confined to the lung is effectively treated with pulmonary metastasectomyYan Shi, James I Geller, Irene T Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group StudyTerzah M Horton, Patrick A Thompson, Stacey L Berg, et al.
Journal of Pediatric Surgery|March 10, 2015
Focal nodular hyperplasia in children: an institutional experience with review of the literatureIrene T Ma, Yesenia Rojas, Prakash M Masand, et al.
Cancer Chemotherapy and Pharmacology|June 16, 2009
Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primatesJodi A Muscal, Patrick A Thompson, Vincent L Giranda, et al.
Pediatric Blood & Cancer|August 14, 2012
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916)Jodi A Muscal, Patrick A Thompson, Terzah M Horton, et al.
Neuro-Oncology|April 18, 2013
Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomasLindsay B Kilburn, Mehmet Kocak, Franziska Schaedeli Stark, et al.
Pageof 4